Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 74.70 |
P170185
Active
Maja Andjelkovic , Ruvejda Aliefendic
Republic of Serbia
Serbia
May 21, 2019
(as of board presentation)
December 13, 2019
May 18, 2020
US$ 48.00 million
Ministry of Science, Technological Development and Innovation (NITRA)
2020
US$ 74.70 million
N/A
April 8, 2024
September 30, 2027
Yes
BANK APPROVED
Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 74.70 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | 74.70 |
IDA Commitment | N/A |
IBRD + IDA Commitment | 74.70 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 48.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Jun 28, 2023 | IBRD-90290 | Loan Disb | 1,853,586.00 |
Nov 15, 2023 | IBRD-90290 | Int Charges | 25,337.99 |
May 15, 2024 | IBRD-90290 | Loan Repay | 1,820,261.80 |
May 15, 2024 | IBRD-90290 | Int Charges | 657,156.75 |
Dec 13, 2019 | IBRD-90290 | Loan Commitment | 48,000,000.00 |
May 18, 2020 | IBRD-90290 | Loan Disb | 116,229.00 |
May 18, 2020 | IBRD-90290 | Fee Charges | 116,229.00 |
Oct 19, 2020 | IBRD-90290 | Loan Disb | 823,725.00 |
Oct 19, 2020 | IBRD-90290 | Loan Disb | 882,562.50 |
Oct 19, 2020 | IBRD-90290 | Loan Disb | 2,353,500.00 |
Nov 19, 2021 | IBRD-90290 | Loan Disb | 1,052,774.10 |
Nov 15, 2020 | IBRD-90290 | Int Charges | 28,810.42 |
Nov 15, 2020 | IBRD-90290 | Int Charges | 62,959.85 |
Nov 15, 2020 | IBRD-90290 | Int Charges | 229.98 |
May 15, 2021 | IBRD-90290 | Int Charges | 357.66 |
May 15, 2021 | IBRD-90290 | Int Charges | 59,195.35 |
May 15, 2021 | IBRD-90290 | Int Charges | 770.81 |
Jul 22, 2021 | IBRD-90290 | Loan Disb | 87,096.68 |
Oct 3, 2022 | IBRD-90290 | Loan Disb | 512,539.88 |
Oct 3, 2022 | IBRD-90290 | Loan Disb | 2,925,110.80 |
Nov 15, 2022 | IBRD-90290 | Int Charges | 43,633.07 |
Nov 15, 2022 | IBRD-90290 | Int Charges | 13,120.73 |
Aug 24, 2022 | IBRD-90290 | Loan Disb | 317,504.00 |
Dec 30, 2021 | IBRD-90290 | Loan Disb | 1,699,125.00 |
Jul 14, 2022 | IBRD-90290 | Loan Disb | 1,348,828.10 |
Mar 21, 2022 | IBRD-90290 | Loan Disb | 883,600.00 |
Mar 21, 2022 | IBRD-90290 | Loan Disb | 210,959.50 |
May 15, 2022 | IBRD-90290 | Int Charges | 47,686.39 |
Jun 24, 2022 | IBRD-90290 | Loan Disb | 531,968.10 |
Nov 15, 2021 | IBRD-90290 | Int Charges | 56,853.86 |
Sep 25, 2023 | IBRD-90290 | Loan Disb | 531,900.00 |
Jun 2, 2023 | IBRD-90290 | Loan Disb | 473,424.84 |
Jul 12, 2023 | IBRD-90290 | Loan Disb | 507,012.00 |
May 15, 2023 | IBRD-90290 | Int Charges | 237,823.81 |
May 15, 2023 | IBRD-90290 | Loan Repay | 1,092,753.90 |
May 15, 2023 | IBRD-90290 | Int Charges | 1,302.64 |
Feb 24, 2023 | IBRD-90290 | Loan Disb | 423,180.00 |
Feb 24, 2023 | IBRD-90290 | Loan Disb | 3,173,850.00 |
Apr 28, 2023 | IBRD-90290 | Loan Disb | 2,250,416.80 |
Jan 31, 2023 | IBRD-90290 | Loan Disb | 1,488,313.40 |
Apr 25, 2023 | IBRD-90290 | Loan Disb | 617,176.00 |
Apr 25, 2023 | IBRD-90290 | Loan Disb | 858,556.75 |
May 15, 2023 | IBRD-90290 | Int Charges | 229.41 |
May 15, 2023 | IBRD-90290 | Int Charges | 36,519.11 |
Nov 15, 2022 | IBRD-90290 | Int Charges | 388.70 |
Oct 3, 2022 | IBRD-90290 | Loan Disb | 537,845.00 |
May 15, 2024 | IBRD-90290 | Int Charges | 373.37 |
May 15, 2024 | IBRD-90290 | Int Charges | 5,880.19 |
May 15, 2024 | IBRD-90290 | Int Charges | 19,417.70 |
Jun 26, 2024 | IBRD-90290 | Loan Disb | 641,100.00 |
Feb 16, 2024 | IBRD-90290 | Loan Disb | 732,684.90 |
Nov 15, 2023 | IBRD-90290 | Int Charges | 532,574.94 |
Nov 27, 2023 | IBRD-90290 | Loan Disb | 547,700.00 |
Oct 19, 2023 | IBRD-90290 | Loan Disb | 971,319.10 |
Dec 22, 2023 | IBRD-90290 | Loan Disb | 1,803,853.60 |
Nov 15, 2023 | IBRD-90290 | Loan Repay | 1,538,991.80 |
Nov 15, 2023 | IBRD-90290 | Int Charges | 458.53 |
Nov 15, 2023 | IBRD-90290 | Int Charges | 4,730.01 |
Jun 28, 2023 | IBRD-90290 | Loan Disb | 1,110,700.90 |
Name | Review | Date |
---|---|---|
Overall Implementation Progress (IP) | Satisfactory | 2024-12-03 |
Procurement | Satisfactory | 2024-12-03 |
Progress towards achievement of PDO | Satisfactory | 2024-12-03 |
Project Management | Satisfactory | 2024-12-03 |
Financial Management | Satisfactory | 2024-12-03 |
Monitoring and Evaluation | Satisfactory | 2024-12-03 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of scientific publications in top 10 percent of internationally recognized journals (annual, not cumulative) | Value | 1000.00 | 955.00 | 1150.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
External investment generated by participating companies (USD million) | Value | 0.00 | 24.50 | 7.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2023 | |
Comment |
Number of collaborative applied research projects | Value | 0.00 | 515.00 | 400.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of new or improved innovative products or services introduced to the market | Value | 0.00 | 56.00 | 80.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of enterprises completing acceleration program | Value | 0.00 | 39.00 | 120.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Amount of grant awards by SF, cumulative (USD million) | Value | 0.00 | 17.60 | 43.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Establishment of Institutional Funding of SROs | Value | Law on Science and Research adopted | Partially implemented: new temporary institutional | New financing model implemented |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of diaspora members participating in the program | Value | 0.00 | 0.00 | 70.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of internal assessment of RDIs | Value | 0.00 | 61.00 | 60.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of Serbian researchers participating in the program | Value | 0.00 | 0.00 | 150.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Percentage of which have at least one woman founder | Value | 0.00 | 0.00 | 10.00 |
Date | ||||
Comment |
Percentage of which going to projects with women principal investigators | Value | 0.00 | 0.00 | 15.00 |
Date | ||||
Comment |
Number of accelerated enterprises achieving at least 10% annual growth one year after the program | Value | 0.00 | 0.00 | 40.00 |
Date | December 31, 2019 | August 8, 2023 | June 30, 2025 | |
Comment |
Amount of international funds attracted by SF supported projects (USD million) | Value | 0.00 | 2.00 | 5.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of external assessments of RDIs | Value | 0.00 | 20.00 | 20.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Percent of which are women | Value | 0.00 | 0.00 | 15.00 |
Date | ||||
Comment |
Percentage of SF and IF survey respondents who report in annual surveys that effective engagement processes have been established | Value | 0.00 | 72.00 | 65.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of publications supported by SF programs | Value | 0.00 | 1326.00 | 780.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of RDIs executing transformation plans | Value | 0.00 | 18.00 | 18.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of joint publications by local and diaspora researchers | Value | 0.00 | 0.00 | 20.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of collaborations between participating RDIs and private sector/international entities | Value | 0.00 | 443.00 | 200.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of international R&D institutions participating in the Program | Value | 0.00 | 0.00 | 20.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |
Number of SF staff trained | Value | 0.00 | 39.00 | 40.00 |
Date | December 31, 2019 | March 27, 2024 | June 30, 2025 | |
Comment |